U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H14O4
Molecular Weight 270.28
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIPHENYL DIMETHYL DICARBOXYLATE

SMILES

COC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)OC

InChI

InChIKey=BKRIRZXWWALTPU-UHFFFAOYSA-N
InChI=1S/C16H14O4/c1-19-15(17)13-7-3-11(4-8-13)12-5-9-14(10-6-12)16(18)20-2/h3-10H,1-2H3

HIDE SMILES / InChI

Description

BIPHENYL DIMETHYL DICARBOXYLATE (BDD) under the brand name Nissel is used in the South Corea for the treatment of chronic hepatitis followed by an increase in serum alanine aminotransferase levels continuously. This compound also participated in clinical trials phase III in the patients with chronic liver disease. In addition, the drug was studied in phase III clinical trials after laparoscopic cholecystectomy. The use of BDD in patients with cholecystitis was expected to inhibit elevated liver enzyme levels and to maintain liver function.

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Dimethyl biphenyl-4,4'-dicarboxyl-ate.
2009 Jun 24
Patents

Patents

07582364
1
20090214860
1
JPH11130733A
1

Sample Use Guides

In Vivo Use Guide
Biphenyl Dimethyl Dicarboxylate 25mg & garlic oil 50mg: 1cap. 2cap T.I.D
Route of Administration: Oral
Name Type Language
BIPHENYL DIMETHYL DICARBOXYLATE
Common Name English
Dimethyl 4,4'-biphenyldicarboxylate [WHO-DD]
Common Name English
DIMETHYL 4,4'-BIPHENYLDICARBOXYLATE
WHO-DD  
Systematic Name English
(1,1'-BIPHENYL)-4,4'-DICARBOXYLIC ACID, DIMETHYL ESTER
Common Name English
4,4'-BIPHENYLDICARBOXYLIC ACID, DIMETHYL ESTER
Common Name English
4,4'-BIS(METHOXYCARBONYL)BIPHENYL
Systematic Name English
DIMETHYL (1,1'-BIPHENYL)-4,4'-DICARBOXYLATE
Systematic Name English
NISSEL
Brand Name English
Code System Code Type Description
EPA CompTox
DTXSID2061143
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
DRUG BANK
DB12475
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
FDA UNII
K61BXA0U9C
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
PUBCHEM
13099
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
ECHA (EC/EINECS)
212-341-4
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
SMS_ID
100000126109
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
CAS
792-74-5
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
HSDB
5754
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
EVMPD
SUB33007
Created by admin on Fri Dec 15 15:00:49 GMT 2023 , Edited by admin on Fri Dec 15 15:00:49 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966